SIRT6 Protein

SIRT6 Protein

Introduction

Sirt6 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@kawahara2009]
<div class="infobox-header">SIRT6</div> [@zhong2012]
<div class="infobox-content"> [@van2011] Protein Name: Sirtuin 6 (Nuclear/Mitochondrial)<br> Gene: SIRT6<br> UniProt ID: Q9Y5W5<br> PDB Structures: 3K34, 3ZG6, 5YIK<br> Molecular Weight: 36 kDa<br> Subcellular Localization: Nucleus, Mitochondria<br> Protein Family: Sirtuin family (Class III deacetylases)
</div>
</div>

Overview

SIRT6 (Sirtuin 6) is a NAD+-dependent nuclear and mitochondrial enzyme with deacetylase and ADP-ribosyltransferase activities. It functions as a chromatin regulator controlling DNA repair, gene expression, genome stability, inflammation, and metabolism. Often called a "longevity protein," SIRT6 has emerged as an important protective factor in neurodegenerative diseases through its roles in maintaining genomic integrity and regulating stress responses.

Structure

SIRT6 has the characteristic sirtuin core domain:

• NAD+-binding Rossmann fold: Conserved catalytic domain
• Extended substrate binding pocket: Accommodates histone tails
• Zinc-binding domain: Stabilizes protein structure
• Nuclear localization signal: Directs nuclear import
• Mitochondrial targeting sequence: Enables mitochondrial localization

SIRT6 Protein

Introduction

Sirt6 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@kawahara2009]
<div class="infobox-header">SIRT6</div> [@zhong2012]
<div class="infobox-content"> [@van2011] Protein Name: Sirtuin 6 (Nuclear/Mitochondrial)<br> Gene: SIRT6<br> UniProt ID: Q9Y5W5<br> PDB Structures: 3K34, 3ZG6, 5YIK<br> Molecular Weight: 36 kDa<br> Subcellular Localization: Nucleus, Mitochondria<br> Protein Family: Sirtuin family (Class III deacetylases)
</div>
</div>

Overview

SIRT6 (Sirtuin 6) is a NAD+-dependent nuclear and mitochondrial enzyme with deacetylase and ADP-ribosyltransferase activities. It functions as a chromatin regulator controlling DNA repair, gene expression, genome stability, inflammation, and metabolism. Often called a "longevity protein," SIRT6 has emerged as an important protective factor in neurodegenerative diseases through its roles in maintaining genomic integrity and regulating stress responses.

Structure

SIRT6 has the characteristic sirtuin core domain:

• NAD+-binding Rossmann fold: Conserved catalytic domain
• Extended substrate binding pocket: Accommodates histone tails
• Zinc-binding domain: Stabilizes protein structure
• Nuclear localization signal: Directs nuclear import
• Mitochondrial targeting sequence: Enables mitochondrial localization

Normal Function

Chromatin Regulation

• H3K9 deacetylation: Maintains heterochromatin, silences repetitive elements
• H3K56 deacetylation: Regulates nucleosome assembly and DNA repair
• Gene expression control: Modulates metabolic and stress-response genes

DNA Repair

• Base excision repair (BER): Promotes repair of oxidative DNA damage
• Double-strand break repair: Facilitates homologous recombination
• Telomere maintenance: Protects chromosome ends

Inflammation Control

• [NF-κB](/entities/nf-kb) suppression: Deacetylates RELA/p65 to inhibit transcription
• TNF production: Reduces pro-inflammatory cytokine expression
• Chronic inflammation: Limits age-related inflammatory processes

Metabolic Regulation

• Glycolysis: Controls glucose metabolism through PFKFB3
• Mitochondrial function: Regulates oxidative phosphorylation
• Stress response: Coordinates cellular adaptation

Role in Disease

Alzheimer's Disease

• SIRT6 protects against [Aβ](/proteins/amyloid-beta)-induced neuronal damage
• Maintains genomic integrity in [neurons](/entities/neurons)
• Reduces neuroinflammation
• [Tau](/proteins/tau) pathology may involve SIRT6 dysregulation
• SIRT6 declines with age and AD progression

Parkinson's Disease

• Protects dopaminergic neurons from oxidative stress
• DNA repair in vulnerable neuronal populations
• Mitochondrial quality control
• May interact with PD-associated genes (LRRK2, Parkin)
• SIRT6 activators show neuroprotection in models

Huntington's Disease

• Counteracts mutant [huntingtin](/proteins/huntingtin) toxicity
• DNA repair deficits are prominent in HD
• Metabolic dysregulation
• SIRT6 promotes clearance of mutant protein

Other Conditions

• Progeria: SIRT6 deficiency causes accelerated aging
• Cancer: SIRT6 acts as tumor suppressor
• Metabolic disease: SIRT6 regulates insulin sensitivity

Therapeutic Targeting

| Agent | Mechanism | Development Stage | Notes |
|-------|-----------|-------------------|-------|
| MDL-801 | SIRT6 activator | Preclinical | Increases H3K9 deaceltion |
| UBCS039 | SIRT6 activator | Preclinical | Specific for SIRT6 |
| NAD+ precursors | Increase activity | Phase II | NR, NMN benefit |
| SRT2104 | Broader sirtuin activator | Phase I | Indirect activation |
| SIRT6 overexpression | Gene therapy | Preclinical | Shows promise |

Key Publications

Cross-Links

• [SIRT6 Gene](/genes/sirt6)
• [SIRT1 Protein](/proteins/sirt1-protein)
• [DNA Repair Pathways](/mechanisms/dna-repair-pathways)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease-disease)

Background

The study of Sirt6 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Amyloid Hypothesis](/mechanisms/amyloid-hypothesis)
• [Tau Pathology](/mechanisms/tau-pathology)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alpha-Synuclein](/mechanisms/alpha-synuclein)

External Links

• [UniProt: Q9Y5W5](https://www.uniprot.org/uniprot/Q9Y5W5)
• [PDB: 3K34](https://www.rcsb.org/structure/3K34)
• [NCBI Protein: SIRT6](https://www.ncbi.nlm.nih.gov/protein/NP_057464)

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [SIRT6-NAD+ Axis Enhancement Therapy](/hypothesis/h-50a535f9) — <span style="color:#ff8a65;font-weight:600">0.38</span> · Target: SIRT6